Stock & Company Details
HCW Biologics Inc $HCWB
Price:
46,691,331
1.6M
$6.1M
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
-0.91
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
HCWB technical indicators
Latest HCW Biologics Inc (HCWB) technical indicators as of 2026-07-21: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
51.93 11.8%
MACD:
0.58 14.1%
SMA 50:
$2.26 2.8%
SMA 200:
$1.78 0.1%
EMA 20:
$3.53 0.5%
Bollinger Bands:
6.44 / 0.59
Stochastic:
26.48 41.7%
ADX 14:
38.34 5.3%
ATR 14:
0.45 7.1%
CCI 20:
-1.55 107.2%
OBV:
1.27B 0.0%
ROC 12:
-21.40% 30.7%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company believes age-related low-grade chronic inflammation is a significant contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases.
Finance Bot
Ask your questions
Start by typing a question below.
